Impact of achieved blood pressures on mortality risk and end-stage renal disease among a large, diverse hypertension population

Journal of the American College of Cardiology

Volumn 64, Issue 6, 2014, Pages 588-597

  Sim, John J ^a   Shi, Jiaxiao ^b   Kovesdy, Csaba P ^c   Kalantar Zadeh, Kamyar ^d   Jacobsen, Steven J ^b  

^a LOS ANGELES MEDICAL CENTER   (United States)

^b Department of Research and Evaluation Kaiser Permanente Southern California ^*  (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

blood pressure goals; hypertension treatment; mortality risk; renal failure risk; treatment risk

Indexed keywords

BLOOD PRESSURE GOALS; HYPERTENSION TREATMENT; MORTALITY RISK; RENAL FAILURE RISK; TREATMENT RISK;

AGED; BLOOD PRESSURE; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 84905693361     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.04.065     Document Type: Article

References (41)

1. J.A. Cutler, P.D. Sorlie, M. Wolz, T. Thom, L.E. Fields, and E.J. Roccella Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004 Hypertension 52 2008 818 827
2. B.M. Egan, Y. Zhao, and R.N. Axon US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008 JAMA 303 2010 2043 2050
3. S. Lewington, R. Clarke, N. Qizilbash, R. Peto, and R. Collins Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies Lancet 360 2002 1903 1913
4. P.K. Whelton, J. He, and L.J. Appel et al. Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program JAMA 288 2002 1882 1888
5. M.J. Klag, P.K. Whelton, and B.L. Randall et al. Blood pressure and end-stage renal disease in men N Engl J Med 334 1996 13 18
6. Group VACS Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg JAMA 202 1967 1028 1034
7. SHEP Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group JAMA 265 1991 3255 3264
8. F. Turnbull, B. Neal, and T. Ninomiya et al. Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials BMJ 336 2008 1121 1123
9. Group UPDS Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group BMJ 317 1998 703 713
10. L. Hansson, A. Zanchetti, and S.G. Carruthers et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group Lancet 351 1998 1755 1762
11. S. Julius, S.E. Kjeldsen, and M. Weber et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial Lancet 363 2004 2022 2031
12. J.A. Staessen, R. Fagard, and L. Thijs et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators Lancet 350 1997 757 764
13. J.A. Staessen, J. Gasowski, and J.G. Wang et al. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials Lancet 355 2000 865 872
14. W.C. Cushman, G.W. Evans, and R.P. Byington et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus N Engl J Med 362 2010 1575 1585
15. L.J. Appel, J.T. Wright Jr., and T. Greene et al. Intensive blood-pressure control in hypertensive chronic kidney disease N Engl J Med 363 2010 918 929
16. JATOS Study Group Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS) Hypertens Res 31 2008 2115 2127
17. T. Ogihara, T. Saruta, and H. Rakugi et al. Target blood pressure for treatment of isolated systolic hypertension in the elderly: valsartan in elderly isolated systolic hypertension study Hypertension 56 2010 196 202
18. O.R. Benavente, C.S. Coffey, and R. Conwit et al. Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial Lancet 382 2013 507 515
19. J.T. Wright Jr., G. Bakris, and T. Greene et al. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial JAMA 288 2002 2421 2431
20. K. Iseki, F. Miyasato, and K. Tokuyama et al. Low diastolic blood pressure, hypoalbuminemia, and risk of death in a cohort of chronic hemodialysis patients Kidney Int 51 1997 1212 1217
21. F.K. Port, T.E. Hulbert-Shearon, and R.A. Wolfe et al. Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients Am J Kidney Dis 33 1999 507 517
22. C.P. Kovesdy, A.J. Bleyer, and M.Z. Molnar et al. Blood Pressure and Mortality in U.S. Veterans With Chronic Kidney DiseaseA Cohort Study Annals of Internal Medicine 159 2013 233 242
23. S. Yusuf, K.K. Teo, and J. Pogue et al. Telmisartan, ramipril, or both in patients at high risk for vascular events N Engl J Med 358 2008 1547 1559
24. S. Bangalore, F.H. Messerli, and C.C. Wun et al. J-curve revisited: An analysis of blood pressure and cardiovascular events in the Treating to New Targets (TNT) Trial Eur Heart J 31 2010 2897 2908
25. P. Ruggenenti, A. Perna, and G. Loriga et al. Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial Lancet 365 2005 939 946
26. S. Verma, M. Gupta, and D.T. Holmes et al. Plasma renin activity predicts cardiovascular mortality in the Heart Outcomes Prevention Evaluation (HOPE) study Eur Heart J 32 2011 2135 2142
27. C. Koebnick, A.M. Langer-Gould, and M.K. Gould et al. Sociodemographic characteristics of members of a large, integrated health care system: comparison with US Census Bureau data Perm J 16 2012 37 41
28. S.K. Bhandari, S. Pashayan, and I.L. Liu et al. 25-hydroxyvitamin D levels and hypertension rates J Clin Hypertens (Greenwich) 13 2011 170 177
29. A.S. Levey, L.A. Stevens, and C.H. Schmid et al. A new equation to estimate glomerular filtration rate Ann Intern Med 150 2009 604 612
30. J.J. Sim, S.K. Bhandari, and J. Shi et al. Characteristics of resistant hypertension in a large, ethnically diverse hypertension population of an integrated health system Mayo Clin Proc 88 2013 1099 1107
31. J.J. Sim, S.K. Bhandari, and J. Shi et al. Plasma renin activity (PRA) levels and antihypertensive drug use in a large healthcare system Am J Hypertens 25 2011 379 388
32. J.J. Sim, J. Handler, S.J. Jacobsen, and M.H. Kanter Systemic implementation strategies to improve hypertension: the Kaiser Permanente Southern California experience Can J Cardiol 30 2014 544 552
33. A.S. Go, G.M. Chertow, D. Fan, C.E. MCCulloch, and C.Y. Hsu Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N Engl J Med 351 2004 1296 1305
34. A. Zanchetti Blood pressure targets of antihypertensive treatment: up and down the J-shaped curve Eur Heart J 31 2010 2837 2840
35. H.M. Perry Jr., B.R. Davis, and T.R. Price et al. Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: the Systolic Hypertension in the Elderly Program (SHEP) JAMA 284 2000 465 471
36. R.M. Cooper-DeHoff, Y. Gong, and E.M. Handberg et al. Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease JAMA 304 2010 61 68
37. A. DeFelice, J. Willard, and J. Lawrence et al. The risks associated with short-term placebo-controlled antihypertensive clinical trials: a descriptive meta-analysis J Hum Hypertens 22 2008 659 668
38. D. Diao, J.M. Wright, D.K. Cundiff, and F. Gueyffier Pharmacotherapy for mild hypertension Cochrane Database Syst Rev 8 2012 CD006742
39. P.A. James, S. Oparil, and B.L. Carter et al. 2014 Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8) JAMA 311 2014 507 520
40. A. Romero-Corral, V.M. Montori, and V.K. Somers et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies Lancet 368 2006 666 678
41. P.H. Diehr, S.M. Thielke, A.B. Newman, C. Hirsch, and R. Tracy Decline in health for older adults: five-year change in 13 key measures of standardized health J Gerontol A Biol Sci Med Sci 68 2013 1059 1067